Covered recipient · General Payments record
RAJANI REDDY KATKURI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$1,475.03
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $231.16 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $85.07 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $59.86 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $35.92 | 2 |
| Abbott Laboratories | $31.10 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.23 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125314882 | CMS |
| Abbott Laboratories | $14.87 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125314884 | CMS |
| AstraZeneca Pharmaceuticals LP | $85.07 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104624844 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $13.57 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086221147 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $22.35 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086119574 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.21 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118203813 | CMS |
| Novartis Pharmaceuticals Corporation | $26.67 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087148722 | CMS |
| Novartis Pharmaceuticals Corporation | $33.19 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087148716 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.